Fig. 1.

Study design flow (a) and teriparatide adherence (b). Panel a shows the study design flow, where n = the number of patients attending each follow-up visit during the treatment and post-treatment phases (independent of teriparatide treatment status). Percentages are based on number of patients initiating teriparatide treatment (n = 3054). Panel b demonstrates number and percentage of patients still taking teriparatide at each timepoint in the study, where n = the number of adherent patients at each time point during the study. *n = the number of participants enrolled at each site at baseline. Numbers of patients attending each visit (panel a) are not equal to numbers of patients still taking teriparatide (panel b) as numbers in panel a are irrespective of treatment status